India to Bahamas: Olaparib Export Trade Route

The India to Bahamas Olaparib corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $50.6K USD. The route is dominated by VAMA HEALTH WORLD LLP, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's olaparib manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $2.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with olaparib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 34.0%, placing it at rank #7 among India's top olaparib export destinations globally.

On the import side, key buyers of Indian olaparib in Bahamas include AS PER INVOICE ASPER INVOICE, PROGRESSIVE PHARMACEUTICAL DISTRIBU, ONCOLOGY CONSULTANTS and 1 others. AS PER INVOICE ASPER INVOICE is the single largest importer with 6 shipments valued at $29.5K USD.

India's olaparib exports to Bahamas are driven primarily by a handful of large-scale manufacturers. VAMA HEALTH WORLD LLP with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Bahamas benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA HEALTH WORLD LLP, SPR ONCOCARE PRIVATE LIMITED, SARA TRADING CORPORATION — together account for 94% of total trade value on this route. The average shipment value of $2.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as olaparib 150 mg natco brand bracnat batch no 2440039 exp date aug 2027 (12 btls) and olaparib 150 mg natco brand -bracanat b/n 2450031 exp dec 2027, suggesting that buyers in Bahamas tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AS PER INVOICE ASPER INVOICE is the largest importer with 6 shipments worth $29.5K USD — representing 58% of all olaparib imports from India on this route.